Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 12/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 12/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 10/20 | 0.68 |
| ▸ | MAPT | P10636 | 10/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 9/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 8/20 | 0.68 |
| ▸ | FTO | Q9C0B1 | 8/20 | 0.68 |
| ▸ | CYP1A1 | P04798 | 8/20 | 0.68 |
| ▸ | CYP1B1 | Q16678 | 8/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.68 |
| ▸ | RECQL | P46063 | 7/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.68 |
| ▸ | XDH | P47989 | 7/20 | 0.68 |
| ▸ | POLH | Q9Y253 | 7/20 | 0.68 |
| ▸ | IP6K2 | Q9UHH9 | 7/20 | 0.68 |
| ▸ | TP53 | P04637 | 6/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kaempferol SCHEMBL28180527 | 0.92 | ABCB1 (0.69) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Quercetin SCHEMBL4303275 | 0.91 | MEN1 (0.74) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Quercetin SCHEMBL10877423 | 0.90 | MEN1 (0.65) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Quercetin SCHEMBL111510 | 0.89 | MEN1 (0.76) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Luteolin SCHEMBL4918304 | 0.88 | CYP3A4 (0.66) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Quercetin SCHEMBL18555282 | 0.88 | KMT2A (0.68) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Morin SCHEMBL6043175 | 0.88 | FTO (0.65) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Luteolin SCHEMBL8161993 | 0.88 | MEN1 (0.72) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Luteolin SCHEMBL1229732 | 0.87 | POLH (0.75) | MEN1KMT2AKDM4ECYP3A4HSD17B10 | |
| Luteolin SCHEMBL15271260 | 0.87 | POLH (0.75) | MEN1KMT2AKDM4ECYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113229505-A | Anti-aging collagen peptide and preparation method thereof | 杭州葆瑞生物科技有限公司 | 2021-08-10 | — | — | CN | claimed |
| CN-116998685-A | Preparation method of haw extract | 福建红果宝健康产业有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116920019-A | Application of haw extract in preparing medicine for treating constipation | 福建红果宝健康产业有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116920018-A | Hawthorn fruit extract and application thereof | 福建红果宝健康产业有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116898906-A | Application of haw extract in preparing medicine for treating cancer pain | 福建红果宝健康产业有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116099467-A | Quercetin microcapsule and preparation method thereof | 吉林大学 | 2023-05-12 | — | — | CN | disclosed |
| CN-113229505-A | Anti-aging collagen peptide and preparation method thereof | 杭州葆瑞生物科技有限公司 | 2021-08-10 | — | — | CN | disclosed |
| CN-106102757-B | Anti-neuritis and protective compounds in yarrow | 以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 | 2021-06-25 | — | — | CN | disclosed |
| CN-106811440-B | Method for separating and culturing buffalo mammary epithelial cells from buffalo milk | 广西壮族自治区水牛研究所 | 2020-09-15 | — | — | CN | disclosed |
| CN-111093642-A | Expression of PD-L1 inhibition and expression of PD1 enhancement | IN原料公司 | 2020-05-01 | — | — | CN | disclosed |
| US-20040235965-A1 | Utilization of rutins and aescins in the treatment of circulatory disturbances of the ear | BRENCH AG (DE) | 2004-11-25 | — | — | US | disclosed |
| US-5922316-A | ADDING GENE-INDUCING FLAVONOID | MCGILL UNIVERSITY (CA) | 1999-07-13 | — | — | US | disclosed |
| US-5872223-A | TREATING CANCERS AND AUTOIMMUNE DISEASES IN HUMANS ARE PROVIDED WHICH COMPRISE A TYROSINE KINASE INHIBITOR LINKED TO A LIGAND TARGETING A CELL SURFACE RECEPTOR WHICH ARE SPECIFICALLY CAPABLE OF INHIBITING RECEPTOR ASSOCIATED | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1999-02-16 | — | — | US | disclosed |
| EP-0776338-B1 | IMMUNOCONJUGATES COMPRISING TYROSINE KINASE INHIBITORS | UNIV MINNESOTA (US) | 1998-12-09 | — | — | EP | disclosed |
| EP-0776338-A1 | IMMUNOCONJUGATES COMPRISING TYROSINE KINASE INHIBITORS | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1997-06-04 | — | — | EP | disclosed |
| US-5587459-A | LINKED TO A LIGAND TARGETING A CELL SURFACE RECEPTOR; FOR TREATING CANCERS AND AUTOIMMUNE DISEASES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1996-12-24 | — | — | US | disclosed |
| WO-1996006116-A9 | IMMUNOCONJUGATES COMPRISING TYROSINE KINASE INHIBITORS | — | 1996-03-28 | — | — | WO | disclosed |
| WO-1996006116-A1 | IMMUNOCONJUGATES COMPRISING TYROSINE KINASE INHIBITORS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1996-02-29 | — | — | WO | disclosed |
| US-5141745-A | Gene expression | THE LUBRIZOL CORPORATION (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0245931-A2 | Nodulation inducing factors | LUBRIZOL GENETICS INC. (US) | 1987-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235965-A1 | Utilization of rutins and aescins in the treatment of circulatory disturbances of the ear | ECHS1, CIAPIN1, WFS1 | MEN1 1045/4885KMT2A 4476/4885KDM4E 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.